Professor Akimichi Morita graduated from Nagoya City University and received his MD in 1989. He subsequently earned his PhD in basic immunology from the Aichi Cancer Center in Nagoya. As a Humboldt Foundation Fellow, he studied photobiology and photoimmunology at Heinrich Heine University Düsseldorf, Germany. He later pursued further training at the University of Texas Southwestern Medical Center in Dallas, Texas, United States.

Since then, he has played a leading role in introducing and establishing standard phototherapies in Japan. He was appointed Professor and Chairman of the Department of Geriatric and Environmental Dermatology at Nagoya City University Graduate School of Medical Sciences in 2003. He has also served as Vice Director of Nagoya City University Hospital and Vice President of Nagoya City University.

From April 2026, he serves as Director of Nagoya City University West Medical Center, while continuing his professorship at the Graduate School of Medical Sciences. His primary research interests include photobiology, phototherapy, cutaneous immunology, skin aging, cutaneous T-cell lymphoma, and psoriasis.

Professor Morita served as President of the Japanese Society for Psoriasis Research (2022–2026) and has been a Board Member of the International Psoriasis Council (IPC) since 2023. He also served as President of the Japanese Society for Photomedicine and Photobiology (2018–2022) and the Japanese Society for Investigative Dermatology (JSID) (2017–2020).

He is an editorial board member of several prestigious medical journals. He served as Editor-in-Chief of Experimental Dermatology until December 2025. He previously served as Editor-in-Chief of Photodermatology, Photoimmunology & Photomedicine (2018–2021) and the Journal of Dermatological Science (2008–2013).

In addition, he has published over 300 peer-reviewed articles (H-index: 58) and authored or co-authored 26 books and book chapters.